Literature DB >> 31392221

Biomarkers in Shock Patients and Their Value as A Prognostic Tool; A Prospective Multi-Center Cohort Study.

Ana Maria Navio Serano1, Joaquín Valle Alonso2, Gustavo Rene Piñero3, Alejandro Rodriguez Camacho4, Josefa Soriano Benet5, Manuel Vaquero6.   

Abstract

OBJECTIVE: To investigate the prognostic value of clinical and laboratory tests in prediction of outcome in patients at day 30 post presentation to hospital with shock and to determine the prognostic value of mid regional pro-adrenomedullin (MR-proADM) on mortality prediction at 30 days in the same patient cohort.
METHOD: This prospective multicenter cohort study analyzed data from patients who had presenting with shock to the emergency departments of eleven urban, tertiary-care University hospitals in Spain between March, 2011 and May, 2011. Recruitment of patients was via convenience sampling. Inclusion criteria included age between 14 and 100 years with clinical diagnostic criteria of shock on admission. Various patient parameters were analysed, such as age, sex, past medical history. Other clinical variables were measured on arrival to hospital, including sequential organ failure assessment score (score SOFA), blood pressure, oxygen saturations, capillary refill time and shock index (SI). Laboratory variables investigated included base excess, MR-proADM, lactate, C-Reactive Protein (CRP) and procalcitonin (PCT).
RESULTS: There were 212 patients included in the study from the eleven hospitals involved. The mean age was 72.2 years old and 60.4% of the patients were men. In the discriminant analysis only age, MR-proADM and PCT remained in the final discriminant equation. The separate analysis of MR-proADM showed that, in the non-survivors group, MR-proADM levels are significantly higher than those found in the group of survivors (p<0.001).
CONCLUSION: Age, PCT and MR-proADM were useful to predict short-term mortality in patients presenting to the emergency department shock. This suggests that PCT and MR-proADM in combination with the most common prediction models will improve prognostic value.

Entities:  

Keywords:  Biomarkers; Patients; Prognostic tool; Shock

Year:  2019        PMID: 31392221      PMCID: PMC6681889          DOI: 10.29252/beat-070304

Source DB:  PubMed          Journal:  Bull Emerg Trauma        ISSN: 2322-2522


  29 in total

1.  Prognostic value of procalcitonin in community-acquired pneumonia.

Authors:  P Schuetz; I Suter-Widmer; A Chaudri; M Christ-Crain; W Zimmerli; B Mueller
Journal:  Eur Respir J       Date:  2010-07-01       Impact factor: 16.671

2.  Prognostic value of blood lactate levels: does the clinical diagnosis at admission matter?

Authors:  Tim C Jansen; Jasper van Bommel; Paul G Mulder; Alexandre P Lima; Ben van der Hoven; Johannes H Rommes; Ferdinand T F Snellen; Jan Bakker
Journal:  J Trauma       Date:  2009-02

3.  Procalcitonin and C-reactive protein levels as diagnostic tools in febrile patients admitted to a General Internal Medicine ward.

Authors:  Raul Ruiz-Esteban; Pilar Relea Sarabia; Emilio García Delgado; Carlos Barros Aguado; Jose Amerigo Cuervo-Arango; Manuel Varela
Journal:  Clin Biochem       Date:  2011-10-12       Impact factor: 3.281

4.  Proadrenomedullin, a useful tool for risk stratification in high Pneumonia Severity Index score community acquired pneumonia.

Authors:  Caroline Courtais; Nils Kuster; Anne-Marie Dupuy; Margit Folschveiller; Riad Jreige; Anne-Sophie Bargnoux; Julie Guiot; Sophie Lefebvre; Jean-Paul Cristol; Mustapha Sebbane
Journal:  Am J Emerg Med       Date:  2012-09-20       Impact factor: 2.469

5.  Prognostic value of proadrenomedullin in severe sepsis and septic shock patients with community-acquired pneumonia.

Authors:  Borja Suberviola; Alvaro Castellanos-Ortega; Javier Llorca; Fernando Ortiz; David Iglesias; Belen Prieto
Journal:  Swiss Med Wkly       Date:  2012-03-19       Impact factor: 2.193

6.  Early lactate clearance is associated with improved outcome in severe sepsis and septic shock.

Authors:  H Bryant Nguyen; Emanuel P Rivers; Bernhard P Knoblich; Gordon Jacobsen; Alexandria Muzzin; Julie A Ressler; Michael C Tomlanovich
Journal:  Crit Care Med       Date:  2004-08       Impact factor: 7.598

7.  Midregional proadrenomedullin as a prognostic tool in community-acquired pneumonia.

Authors:  David T Huang; Derek C Angus; John A Kellum; Nathan A Pugh; Lisa A Weissfeld; Joachim Struck; Russell L Delude; Matthew R Rosengart; Donald M Yealy
Journal:  Chest       Date:  2009-04-10       Impact factor: 9.410

8.  Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012.

Authors:  R P Dellinger; Mitchell M Levy; Andrew Rhodes; Djillali Annane; Herwig Gerlach; Steven M Opal; Jonathan E Sevransky; Charles L Sprung; Ivor S Douglas; Roman Jaeschke; Tiffany M Osborn; Mark E Nunnally; Sean R Townsend; Konrad Reinhart; Ruth M Kleinpell; Derek C Angus; Clifford S Deutschman; Flavia R Machado; Gordon D Rubenfeld; Steven Webb; Richard J Beale; Jean-Louis Vincent; Rui Moreno
Journal:  Intensive Care Med       Date:  2013-01-30       Impact factor: 17.440

9.  Procalcitonin as a biomarker for early sepsis in the emergency department.

Authors:  Caitlin W Hicks; Rakesh S Engineer; Justin L Benoit; Srinivasan Dasarathy; Robert H Christenson; William F Peacock
Journal:  Eur J Emerg Med       Date:  2014-04       Impact factor: 2.799

10.  Prohormones for prediction of adverse medical outcome in community-acquired pneumonia and lower respiratory tract infections.

Authors:  Philipp Schuetz; Marcel Wolbers; Mirjam Christ-Crain; Robert Thomann; Claudine Falconnier; Isabelle Widmer; Stefanie Neidert; Thomas Fricker; Claudine Blum; Ursula Schild; Nils G Morgenthaler; Ronald Schoenenberger; Christoph Henzen; Thomas Bregenzer; Claus Hoess; Martin Krause; Heiner C Bucher; Werner Zimmerli; Beat Mueller
Journal:  Crit Care       Date:  2010-06-08       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.